PEPGEN INC's ticker is and the CUSIP is 713317105. A total of 57 filers reported holding PEPGEN INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,065,592 | +43.0% | 317,393 | +31.7% | 0.00% | – |
| Q1 2024 | $3,542,435 | +140.2% | 240,982 | +11.1% | 0.00% | – |
| Q4 2023 | $1,475,015 | +32.5% | 216,914 | -1.0% | 0.00% | – |
| Q3 2023 | $1,113,160 | -40.2% | 219,126 | +5.2% | 0.00% | – |
| Q2 2023 | $1,862,595 | -26.0% | 208,344 | +1.2% | 0.00% | – |
| Q1 2023 | $2,516,910 | -48.9% | 205,798 | -44.1% | 0.00% | – |
| Q4 2022 | $4,925,240 | +336.6% | 368,380 | +196.5% | 0.00% | – |
| Q3 2022 | $1,128,000 | +24.5% | 124,253 | +36.2% | 0.00% | – |
| Q2 2022 | $906,000 | – | 91,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 10,689,545 | $157,136,312 | 2.00% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 114,385 | $1,681,460 | 1.11% |
| Frazier Life Sciences Management, L.P. | 1,502,788 | $22,090,984 | 0.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,520,932 | $22,357,700 | 0.83% |
| Octagon Capital Advisors LP | 376,117 | $5,528,920 | 0.66% |
| Sofinnova Investments, Inc. | 503,624 | $7,403,273 | 0.41% |
| Perceptive Advisors | 1,410,438 | $20,733,439 | 0.36% |
| Monashee Investment Management LLC | 85,886 | $1,262,524 | 0.15% |
| Laurion Capital Management LP | 841,431 | $12,369,036 | 0.10% |
| VIKING GLOBAL INVESTORS LP | 1,482,434 | $21,791,780 | 0.08% |